Standard human dosing protocols based on animal studies suggest 0.25-0.5 mg daily via subcutaneous injection for 4-8 weeks
HUBERMAN: And that's one of the major issues with BPC-157 that's not often discussed, which is that if you have a tumor, and tumors thrive on increased blood flow because they like to consume growth factors and increased blood flow means increased growth factors and other things that can not just sustain but actually grow the tumor, well then by taking BPC-157, you may be either maintaining or accelerating the growth of a tumor that would otherwise be removed or stay small
View image online ( Person with furrowed brow, standing by window with their hand on their chest, taking a breath Most heart palpitations are short-lived, dont come with other symptoms and can be managed at home
The intramuscular method helps B12 absorb slowly
current evidence does not support definitive neurological treatment conclusions
This is even more true for menopausal women